Skip to main content
. 2022 Feb 8;8:56. doi: 10.1038/s41420-022-00837-5

Fig. 3. mTORC1 activity during early differentiation affects the overall size of ROs.

Fig. 3

A From day 35 to day 40, rapamycin and MHY1485, which are mTORC1 inhibitor and activator, respectively, were administered daily to investigate the role of mTORC1 in RO. B Light microscopic images of control, rapamycin-treated, and MHY1485-treated ROs at indicated time-points of development. C The average diameter of ROs at indicated time points. Data are expressed by mean ± S.E.M. *p < 0.05 by the Kruskal–Wallis test with post hoc analysis. Scale bar, 100 μm.